- Home
- CIB vs LNTH Comparison
CIB vs LNTH Comparison
Compare CIB & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIB
- LNTH
- Stock Information
- Founded
- CIB 1945
- LNTH 1956
- Country
- CIB Colombia
- LNTH United States
- Employees
- CIB N/A
- LNTH N/A
- Industry
- CIB Commercial Banks
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CIB Finance
- LNTH Health Care
- Exchange
- CIB Nasdaq
- LNTH Nasdaq
- Market Cap
- CIB 7.6B
- LNTH 6.3B
- IPO Year
- CIB 1995
- LNTH 2015
- Fundamental
- Price
- CIB $32.35
- LNTH $94.05
- Analyst Decision
- CIB Strong Sell
- LNTH Strong Buy
- Analyst Count
- CIB 3
- LNTH 6
- Target Price
- CIB $33.67
- LNTH $132.67
- AVG Volume (30 Days)
- CIB 212.5K
- LNTH 723.3K
- Earning Date
- CIB 02-18-2025
- LNTH 02-20-2025
- Dividend Yield
- CIB 9.99%
- LNTH N/A
- EPS Growth
- CIB N/A
- LNTH 304.57
- EPS
- CIB 1.51
- LNTH 6.02
- Revenue
- CIB $5,143,377,225.00
- LNTH $1,496,799,000.00
- Revenue This Year
- CIB N/A
- LNTH $19.64
- Revenue Next Year
- CIB $3.23
- LNTH $5.16
- P/E Ratio
- CIB $5.51
- LNTH $15.62
- Revenue Growth
- CIB 3.66
- LNTH 24.15
- 52 Week Low
- CIB $30.25
- LNTH $50.20
- 52 Week High
- CIB $37.85
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CIB 50.45
- LNTH 53.53
- Support Level
- CIB $31.78
- LNTH $89.92
- Resistance Level
- CIB $33.14
- LNTH $97.25
- Average True Range (ATR)
- CIB 0.54
- LNTH 3.42
- MACD
- CIB 0.01
- LNTH 0.05
- Stochastic Oscillator
- CIB 59.49
- LNTH 67.86
About CIB BanColombia S.A.
BanColombia SA is a financial services company. A conglomerate of financial institutions, BanColombia offers a wide range of product offerings and financial services, including loans to small and midsize enterprises and governments, leasing, factoring, and asset management. The company's operations are in Colombia, Panama, El Salvador, the United States of America, Puerto Rico, Bermuda, and Guatemala.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.